Pfizer Says Early Data Results Show Its COVID-19 Vaccine Is 90% Effective

Inside Edition / YouTube

NEW YORK – Drug maker Pfizer says early data shows its COVID-19 vaccine has an effective rate of more than 90-percent.

That’s a much better than expected efficacy if the trend continues. The so-called interim analysis looked at the first 94 confirmed cases of COVID-19 among the more than 43,000 volunteers.







The volunteers got either two doses of the vaccine or a placebo. The data found that fewer than 10-percent of infections were in participants who had been given the vaccine.

More than 90-percent of the cases were in people who had been given a placebo.





The final goal of the trial is to reach 164 confirmed cases of coronavirus infection.

Pfizer said in a news release it anticipates seeking emergency use authorization from the U.S. Food and Drug Administration by the third week of November.













The company says it expects to have more than a billion doses manufactured next year and it would be free to Americans.

 

Make it easy to keep up to date with more stories like this. Download the WNY News Now mobile app on the Apple App Store and Google Play Store.

 

Have a news tip? Email newsdesk@WNYNewsNow.com, send us a message on Facebook, or Twitter.

WNY News Now encourages an open exchange of opinions and ideas on our stories, however, we ask everyone to follow our comment policy.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.